ERAP1 inhibitor development
<p>ERAP1 has been associated with a set of immune-mediated diseases, including ankylosing spondylitis. Currently, there is no selective and potent ERAP1 inhibitor available that would allow in-depth research of its functions and roles in diseases. Therefore, the aim of this work is to apply fr...
| Auteur principal: | |
|---|---|
| Autres auteurs: | |
| Format: | Thèse |
| Publié: |
2017
|